SAN DIEGO--(BUSINESS WIRE)--Dec 6, 2018--Illumina, Inc. (NASDAQ: ILMN) today announced the launch of its new high-density genotyping array, the Infinium™ Global Diversity Array. This new array was developed for and inspired by the Research Program. The All of Us Research Program is a historic effort to...
Green, 53, is CEO and co-founder of Invenra, a Madison company working on drugs to fight cancer, a company so promising it has forged collaborations with two successful drug companies even though it doesn’t have a single drug in human trials yet. One of the agreements...
Telling the story of how healthcare quality can help build and retain a strong workforce while better connecting young tech-based businesses with the state’s leading healthcare providers are among the missions of the Wisconsin Healthcare Business Forum. The creation of the Healthcare Business Forum was announced...
FluGen Inc., a Madison-based firm (And URP tenant) developing a universal flu vaccine, raised $5.58 million in funding through 36 investors, according to the filing. FluGen, which already has investments from Madison's Venture Investors, the state's largest venture capital fund, recently shared data from its first test on...
Forty young companies will pitch to potential investors and others throughout the course of the Nov. 7-8 Wisconsin Early Stage Symposium at Madison’s Monona Terrace Convention Center. That includes 24 companies selected by conference organizers to present Nov. 7 during the Tech Council Investor Networks tracks...
- Demand accelerated from healthcare providers as more than 11,000 ordered their initial Cologuard test during the third quarter, and nearly 132,000 have ordered since the test was launched - Gross margin increased 320 basis points to 75 percent - Exact Sciences now has in-network contracts with...
Stratatech is starting a test of its StrataGraft skin tissue to see how well it works on children who have suffered serious burns. It’s the first time the Madison company — a subsidiary of British-based Mallinckrodt Pharmaceuticals — will study the use of its engineered skin...
Xconomy Wisconsin — Invenra, a Madison, WI-based startup that develops therapeutic antibodies for pharmaceutical companies and other clients, has raised more than $7.1 million from investors, according to a regulatory filing. Twenty-three investors participated in the equity funding round, according to the filing, which was made public...
UW-Madison's Forward BIO Institute has been awarded $5 million from the National Institutes of Health for tissue manufacturing. The grant was announced yesterday at the Biohealth Summit by Professor Bill Murphy, the institute's director. "This is a unique public-private collaboration that's committed to advancing the global biomanufacturing...
The recently announced Forward BIOLABS will serve as a landing place for startups, many of which will come out of UW-Madison research. That’s according to co-founder Jessica Martin Eckerly. She says the nonprofit’s goal is to establish a fully equipped life sciences laboratory for early-stage companies,...